Medical and Pharmaceutical
Natera (NASDAQ:NTRA) acquired full enrolment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study, which is a prospective, multi-center clinical trial to determine...
Hi, what are you looking for?
Mugglehead Investment Magazine
All posts tagged "U.S. Food and Drug Administration (FDA) Office of Neuroscience"
Business
Here are five companies looking to improve our collective health in different ways.
Health and Safety
The agencies are trying to crack down on the alternative cannabinoid after a surge in availability and adverse events this year
News
After two years of dispute, MAPS is celebrating the decision
